Welcome to our dedicated page for VSee Health news (Ticker: VSEE), a resource for investors and traders seeking the latest updates and insights on VSee Health stock.
VSee Health Inc (VSEE) delivers innovative telehealth solutions through its secure, HIPAA-compliant platform designed for modern healthcare providers. This news hub offers investors and industry professionals timely updates on corporate developments, product innovations, and strategic initiatives shaping the future of digital health.
Access centralized, reliable information on VSee's operational milestones, including earnings announcements, partnership agreements, and regulatory updates. The platform's focus on modular telemedicine tools – from virtual clinics to remote patient monitoring – positions it at the forefront of healthcare technology, making this resource critical for tracking its market impact.
Key updates include financial performance reports, technology enhancements, executive leadership changes, and industry-specific collaborations. Each news item is curated to provide actionable insights for stakeholders evaluating VSee's role in the evolving telehealth landscape.
Bookmark this page for streamlined access to verified VSee Health news, ensuring you stay informed on developments affecting one of telemedicine's most adaptable platforms. Regularly updated to reflect the company's progress in advancing secure, integrated healthcare solutions.
VSee Health (Nasdaq: VSEE) invites investors to a webinar on December 3, 2024, at 4:15 p.m. ET. Hosted by RedChip Companies, the event will feature co-CEOs Imo Aisiku, MD, and Milton Chen, Ph.D., showcasing VSee's AI telehealth solutions that enhance access to quality healthcare globally. The presentation will cover VSee's innovative AI telehealth building blocks, which include fast customization, enterprise scalability, and robust security. The co-CEOs will discuss VSee's journey as a newly public company, highlight its telehealth infrastructure approach, and outline key growth strategies, including recent partnerships and initiatives. A live Q&A session will follow. Register here.
VSee Health (Nasdaq: VSEE) and The TeleDentists have partnered to launch the first virtual oral health compliance service on the PointClickCare Marketplace. The integration provides 24/7/365 on-demand licensed dentists to assist long-term care facilities in meeting CMS oral health care requirements. The service addresses a critical need, as 84% of dependent long-term care residents don't receive necessary dental care due to mobility issues, understaffing, and transportation challenges. The solution enables automatic documentation syncing with PointClickCare's platform, reducing administrative burden while improving care coordination.
VSee Health (NASDAQ: VSEE), Health Tech Without Borders (HTWB), and iDocta are expanding their Project VITAL Africa telehealth pilots in Cameroon, following their commitment at the Clinton Global Initiative 2023. The initiative aims to strengthen healthcare systems in conflict-affected regions through telehealth technology and training. Two pilot programs were launched in Yaoundé in early 2024 using VSee Health's platform. The project is now expanding to include more clinicians and technical experts, enhancing services like telehealth, home visits, and pharmacy requests. The initiative targets regions where over 30 million people need humanitarian and mental health support, particularly addressing areas with high maternal mortality rates.
VSee Health (VSEE) reported Q3 2024 revenue of $3.4 million, up 131% year-over-year. Nine-month revenue reached $6.6 million, a 51% increase from 2023. The company secured key partnerships, including Seven Corners Correctional Health and SkywardRx, while launching innovative programs like Aimee virtual healthcare and GLP-1 telehealth. However, the company recorded a significant net loss of $51.8 million in Q3 2024, primarily due to one-time goodwill impairment charges of $55.0 million. Cash position stood at $2.3 million as of September 30, 2024.
VSee Health (NASDAQ: VSEE) has partnered with BabyLiveAdvice to address maternal care disparities through virtual healthcare services. The collaboration aims to support hospitals and FQHCs in maternity deserts by providing end-to-end virtual maternal care services. The initiative addresses the U.S. maternal health crisis, where maternal mortality rates are notably high, especially among Black women. BabyLiveAdvice's platform, powered by VSee Health's technology, offers comprehensive non-clinical care services from pregnancy through postpartum, helping healthcare providers manage staffing shortages while ensuring continuous patient support.
VSee Health (Nasdaq: VSEE) has successfully demonstrated a groundbreaking telehealth initiative in collaboration with the Kwajalein Atoll Local Government (KALGOV) and Kwajalein Atoll Sustainability Laboratory (KASL). The project aims to improve healthcare access for Marshallese veterans who served in the US military and residents of the Kwajalein Atoll.
The initiative utilizes Starlink satellite technology and VSee Health's telemedicine solution to provide virtual doctor consultations aboard a boat ambulance. The demonstration, concluded on July 25, 2024, showcased the sea-going ambulance boat's ability to connect with healthcare professionals on land using a VSee Telemedicine Kit.
This telehealth solution is expected to significantly enhance the healthcare infrastructure of the Kwajalein Atoll, ensuring timely and expert medical consultations for residents in remote locations, including the outer islands with access to trained health personnel.
VSee Health (Nasdaq: VSEE) announced that co-CEO Milton Chen, PhD, will be a keynote speaker at iA-Med 2024, a symposium focused on AI advancements in healthcare. The event, presented by ProntoMedic, will take place on October 16, 2024, in San Salvador. It aims to promote innovation and collaboration among healthcare professionals in the AI era.
Other keynote speakers include Jesús Seáñez, PhD, co-founder of Hera Diagnostics, and Alejandro Castillo, a technology business leader. The symposium will cover topics such as predictive diagnostics, personalized treatments, and AI-driven healthcare solutions. The agenda includes sessions on healthcare trends, AI applications, and a panel discussion on ethical implications of AI in healthcare.
VSee Health (Nasdaq: VSEE) announced that co-CEO Milton Chen, Ph.D. will participate in a STAR-TIDES Fireside Chat titled "Why Your Digital Health Transformation Will Be Slow and Likely Hacked" on October 22, 2024, at 1:00 p.m. Pacific time. The event, in collaboration with Silicon Valley Forum, will be moderated by STAR-TIDES Chair Aaron Rose and available via Zoom.
Dr. Chen, co-founder of VSee Health, will discuss the company's focus on security compliance, customizability, and patient experience in their telehealth platform. VSee Health offers a secure, no-code, low-code platform with customizable features for virtual care delivery, including an online medical office suite, digital front door mobile app, provider dispatch automation, and remote patient monitoring.
Dr. Chen completed his Ph.D. at Stanford University and has deployed VSee for various high-profile individuals and initiatives providing remote telehealth. Free registration for the Fireside Chat is available online.
VSee Health (Nasdaq: VSEE) reported Q2 2024 financial results and provided a business update. Key highlights include:
- Completed de-SPAC transaction and now publicly traded
- Partnered with Ava Robotics for remote ICU care
- Launched Aimee, a virtual healthcare service
- Contracted with Seven Corners Correctional Health for inmate care
- Expanded services through SkywardRx partnership
- Secured agreement with Premier, Inc.
Financial results:
- Q2 revenue: $1.7 million, up 33% YoY
- Q2 net loss: $0.3 million ($0.06 per share)
- H1 revenue: $3.2 million, up 11% YoY
- H1 net loss: $0.3 million ($0.07 per share)
- Cash and equivalents: $1.1 million as of June 30, 2024
Pro forma results including iDoc acquisition show Q2 revenue of $2.7 million and net loss of $1.8 million ($0.12 per share).
VSee Health (Nasdaq: VSEE) has received a notice from Nasdaq on September 6, 2024, stating that the company is not in compliance with listing rule 5250(c)(1) due to the delayed filing of its Q2 2024 Form 10-Q. This non-compliance does not immediately affect the listing or trading of VSee's stock on The Nasdaq Capital Market. The company has until November 5, 2024 to submit a compliance plan to Nasdaq. If accepted, VSee may be granted up to 180 calendar days (until February 18, 2025) to regain compliance. VSee intends to take necessary steps to file the Form 10-Q and regain compliance as soon as possible.